---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-014446"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2023-11-16T23:59:59+00:00"
generated_at: "2026-06-08T01:27:57.044766+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Dermata Therapeutics receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Nasdaq notice dated Nov 15, 2023 for failing $1.00 minimum bid price for 30 consecutive business days.
- Company has 180 calendar days, until May 13, 2024, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not cured, may qualify for additional 180-day period with reverse stock split and other conditions.
- Company is evaluating options to regain compliance; business operations unaffected.

## SEC filing metadata
- accession: 0001654954-23-014446
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2023-11-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495423014446/0001654954-23-014446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495423014446/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-014446
- JSON: https://secwatch.observer/filing/0001654954-23-014446.json
- Plain text: https://secwatch.observer/filing/0001654954-23-014446.txt

## Key facts
- Listing & Compliance Notices
  Dermata Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: November 15, 2023, Dermata Therapeutics, Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “ Bid Price Requirement ”). The Notice does not result in the immediate delisting of the Company’s common stock from The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000165495423014446/0001654954-23-014446-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.